We are live on ! Find out more
MCM

MAI Capital Management Portfolio holdings

AUM $17.7B
1-Year Est. Return 18.87%
This Fund
S&P 500
This Quarter Est. Return
-1.22%
1 Year Est. Return
+18.87%
3 Year Est. Return
+66.19%
5 Year Est. Return
+78.14%
10 Year Est. Return
+268.52%
AUM
$17.7B
AUM Growth
+$331M
Cap. Flow
+$759M
Cap. Flow %
4.29%
Top 10 Hldgs %
25.25%
Holding
5,160
New
786
Increased
2,627
Reduced
710
Closed
125

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$39.8M
2
JNJ icon
Johnson & Johnson
JNJ
+$17.8M
3
ELV icon
Elevance Health
ELV
+$11.7M
4
BKNG icon
Booking.com
BKNG
+$11.3M
5
ORCL icon
Oracle
ORCL
+$11.2M

Sector Composition

Rank Sector Weight
1 Technology 12.56%
2 Financials 6.28%
3 Healthcare 4.27%
4 Communication Services 4.08%
5 Industrials 4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAPR icon
2651
Capricor Therapeutics
CAPR
$1.14B
$25.3K ﹤0.01%
832
+480
+136% +$12.8K
CECO icon
2652
Ceco Environmental
CECO
$4.42B
$25.3K ﹤0.01%
424
+421
+14,033% +$27.1K
IGLB icon
2653
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.59B
$25.3K ﹤0.01%
509
+205
+67% +$10.4K
ABNB icon
2654
CALL
Airbnb
ABNB
$83.7B
0
WFRD icon
2655
Weatherford International
WFRD
$6.36B
$25.3K ﹤0.01%
267
+173
+184% +$16.3K
WD icon
2656
Walker & Dunlop
WD
$1.65B
$25.2K ﹤0.01%
568
+556
+4,633% +$31.3K
NVMI
2657
Nova
NVMI
$13.9B
$25.2K ﹤0.01%
58
+4
+7% +$1.76K
TWLO icon
2658
CALL
Twilio
TWLO
$29.1B
0
LCTX icon
2659
Lineage Cell Therapeutics
LCTX
$257M
$25.1K ﹤0.01%
15,879
-742
-4% -$1.25K
GLIBK
2660
Liberty Capital Corp Series C GCI Group Common Stock
GLIBK
$876M
$25K ﹤0.01%
673
+124
+23% +$4.69K
HDUS
2661
Hartford Disciplined US Equity ETF
HDUS
$197M
$25K ﹤0.01%
396
KNTK icon
2662
Kinetik
KNTK
$3.71B
$25K ﹤0.01%
516
+16
+3% +$681
MBLY icon
2663
Mobileye
MBLY
$2.03B
$25K ﹤0.01%
3,635
+35
+1% +$317
FOUR icon
2664
Shift4
FOUR
$3.84B
$25K ﹤0.01%
+571
New +$31.5K
TSEM icon
2665
Tower Semiconductor
TSEM
$26.4B
$24.9K ﹤0.01%
142
+11
+8% +$1.48K
IDA icon
2666
Idacorp
IDA
$8.23B
$24.9K ﹤0.01%
174
+159
+1,060% +$21.8K
CET
2667
Central Securities Corp
CET
$1.54B
$24.8K ﹤0.01%
500
LRN icon
2668
Stride
LRN
$3.69B
$24.8K ﹤0.01%
281
+8
+3% +$649
FDIQ
2669
Invesco Bloomberg Financial Data Providers ETF
FDIQ
$51M
$24.6K ﹤0.01%
360
MIR icon
2670
Mirion Technologies
MIR
$4.05B
$24.6K ﹤0.01%
+1,325
New +$29.9K
PRGO icon
2671
Perrigo
PRGO
$1.4B
$24.6K ﹤0.01%
2,293
+2,268
+9,072% +$29.4K
ASIX icon
2672
AdvanSix
ASIX
$567M
$24.6K ﹤0.01%
1,009
+957
+1,840% +$18.1K
ANIK icon
2673
Anika Therapeutics
ANIK
$199M
$24.5K ﹤0.01%
1,691
+386
+30% +$4.48K
ELAN icon
2674
Elanco Animal Health
ELAN
$12.4B
$24.5K ﹤0.01%
1,024
+347
+51% +$8.48K
CION icon
2675
CION Investment
CION
$297M
$24.4K ﹤0.01%
3,562

Similar funds

MAI Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, MAI Capital Management held 5,160 positions worth $17.7B, up 1.9% from $17.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MAI Capital Management deployed $759M of net new capital in Q1 2026, opening 786 new positions and adding to 2,627 existing holdings. Its largest new stake was Compass: 137,278 shares worth $1M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $39.8M trimmed.

  • MAI Capital Management's largest Q1 2026 buy was Compass: 137,278 shares worth $1M.
  • MAI Capital Management added most to Apple in Q1 2026, an estimated $76.7M increase.
  • MAI Capital Management's biggest Q1 2026 reduction was UnitedHealth, cutting an estimated $39.8M.
  • MAI Capital Management fully exited Olympic Steel in Q1 2026, selling an estimated $5.38M.
  • MAI Capital Management's ten largest holdings make up 25% of its $17.7B portfolio in Q1 2026.
  • MAI Capital Management opened 786 new positions and closed 125 in Q1 2026.
  • MAI Capital Management's portfolio value rose 1.9% quarter-over-quarter to $17.7B.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.